ARK Invest Boosts Solana Exposure with Latest SOLQ.U Purchase

Cathie Wood's ARK Invest has made another addition to its Solana ETF holdings. On September 23, the asset manager bought 5,589 units of the 3iQ Solana Staking ETF (SOLQ.U), valuing approximately $53,877.

This is not the first time ARK has purchased SOLQ.U; in fact, it's part of a larger trend of incremental additions to its Solana ETF exposure. On September 5, ARKW bought 1,785 units and ARKF purchased 1,607 units, bringing that day's combined purchase to 3,392 units.

ARK has also been increasing its stakes in genomics-related companies. The fund added $4M worth of Scribe Therapeutics (SCTX), a gene-editing company, through the ARK Genomic Revolution ETF (ARKG). Additionally, ARKG purchased shares of Beam Therapeutics and Veracyte.